GSK Investigational Site

Guayama 00784

0 studies enrolling now · 2 studies all time

What they study most

Measles, Measles-Mumps-Rubella Vaccine, Measles; Mumps; Rubella, Mumps, Rubella

Studies at this site

• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life — Completed
• Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age — Completed